tiprankstipranks

John McKune Insider Profile

4 Followers
John McKune, Corporate Controller & Principal Accounting Office at KalVista Pharmaceuticals, holds 0.00 shares in KalVista Pharmaceuticals (Ticker: KALV), holds 61.81K shares in Pulmonx (Ticker: LUNG). Most recently, John McKune ― shares of KalVista Pharmaceuticals on ― for an estimated value of ―.
tipranks
John McKune

John McKune
KalVista Pharmaceuticals (KALV)
Corporate Controller & Principal Accounting Office

Ranked #47,459 out of 98,743 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+3.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$574K
100.00%
0.00%
A breakdown of John McKune's holdings

Insider Roles

Pulmonx
(LUNG)
INTERIM CFO
KalVista Pharmaceuticals
(KALV)
Corporate Controller & Principal Accounting Office
Roles that John McKune holds in companies

Most Profitable Insider Trade

Stock:
Pulmonx
(LUNG)
Rating:Informative Sell
Date:Dec 05, 2023 - Today
Return:+15.40%
The most profitable trade made by John McKune

John McKune's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KalVista Pharmaceuticals
Corporate Controller & Principal Accounting Office
$0.00
Pulmonx
Mar 05, 2024
INTERIM CFO
Uninformative Buy
$573.60K
List of latest transactions for each holding click on a transaction to see John McKune's performance on stock

John McKune insider profile FAQ

What is the percentage of profitable transactions made by John McKune?
The percentage of profitable transactions made by John McKune is 50%.
    What is the average return per transaction made by John McKune?
    The average return per transaction made by John McKune is 3.10%.
      What stocks does John McKune hold?
      John McKune holds: KALV, LUNG stocks.
        What was John McKune’s latest transaction?
        John McKune latest transaction was an Uninformative Buy of ―.
          What was John McKune's most profitable transaction?
          John McKune’s most profitable transaction was an Informative Sell of LUNG stock on December 5, 2023. The return on the trade was 15.40%.
            What is John McKune's role in KalVista Pharmaceuticals?
            John McKune's role in KalVista Pharmaceuticals is Corporate Controller & Principal Accounting Office.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.